ExploreWatchlistsPricing
  1. JP-listed companies
  2. kainos loboratories,inc
  3. Financials
  4. Operating margin (%)

kainos loboratories,inc (4556)

Market cap
¥10.4B
P/E ratio
16x
Kainos manufactures diagnostic pharmaceuticals, laboratory reagents, and medical devices for hospitals and research facilities to improve healthcare quality.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating margin (%) YoY (%)
Mar 31, 202613.6-12.13%
Mar 31, 202515.5-9.28%
Mar 31, 202417.1+2.60%
Mar 31, 202316.7+2.93%
Mar 31, 202216.2+9.11%
Mar 31, 202114.9+12.43%
Mar 31, 202013.2+6.14%
Mar 31, 201912.4+19.61%
Mar 31, 201810.4+3.05%
Mar 31, 201710.1+21.99%
Mar 31, 20168.3+12.90%
Mar 31, 20157.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat